ThaMa-Vet’s participation in PEAK 2025, which took place from April 8 to 10, 2025, in Minneapolis, Minnesota, marked another milestone in the company’s commitment to supporting the poultry sector with high-performance, precision-engineered veterinary equipment.
During event, the company’s management team engaged in numerous one-on-one discussions with poultry growers, vaccination companies, and industry stakeholders from across the United States and beyond.
These meetings proved to be not only productive but highly instructive. The feedback received from growers was particularly valuable, offering practical insights that will inform future developments and refinements to our product line.
“The face-to-face conversations we had at PEAK 2025 were very meaningful for us,” concluded Hadas Kazs-Shive, Marketing Manager of ThaMa-Vet. “Growers shared their experiences, challenges, and expectations openly, and their input will directly shape our innovation pipeline going forward.
PEAK is the largest trade show and convention in North America focused exclusively on the business and food production of poultry. The company showcased at the event its wide range of advanced poultry syringes, including high-durability automatic syringes designed for efficient, accurate dosing under challenging field conditions. Visitors showed strong interest in the ergonomic design and proven reliability of ThaMa-Vet vaccinators, which have been developed with both performance and user comfort in mind.
ThaMa-Vet’s U.S. distribution partner, Agri-Pro Enterprises of Iowa, was also presenting the company’s poultry syringes at the event. Their longstanding presence and trusted relationships within the animal health sector make them an ideal partner in our efforts to expand accessibility and support in the US.
As the industry continues to navigate growing concerns around Avian Influenza, many discussions naturally turned to the topic of vaccination. The sector is currently awaiting the FDA’s anticipated approval of vaccination protocols, a development that may significantly reshape disease management strategies in the coming months.
As part of the global effort to curb the spread of bird flu, many growers are already using ThaMa 222 syringe that allows two vaccines to be injected at different dosages in a single shot.
Once a vaccination plan is approved in the U.S., ThaMa-Vet is ready to immediately supply these cutting-edge syringes.
